Clinical Trial Update: Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial exploring the effect of dihydromyr icetin on glycemic control, insulin sensitivity, and insulin secretion in type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dihydromirycetin (dihydromirycetin)

Snippet

Sponsor: University of Guadalajara | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: UNKNOWN